Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas

Extrapulmonary poorly differentiated neuroendocrine carcinoma (PDNEC) is a rare and highly aggressive neoplasm for which the optimal chemotherapy remains unclear. The objective of this study was to evaluate the outcomes of patients with PDNEC treated with cisplatin and irinotecan (IP) and perform a...

詳細記述

保存先:
書誌詳細
主要な著者: Ramella Munhoz, Rodrigo, de Mendonça Rego, Juliana Florinda, de Celis Ferrari, Anezka Rubim, Ignez Braghiroli, Maria, Mendonça Bariani, Giovanni, Marcelo Hoff, Paulo, Perego Costa, Frederico, Eduardo Flesch Pfiffer, Túlio, Riechelmann, Rachel
フォーマット: Artigo
言語:Inglês
出版事項: PAGEPress Publications, Pavia, Italy 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804814/
https://ncbi.nlm.nih.gov/pubmed/24179651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2013.e39
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料